Baraah Al Ahmad Nachar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Baraah Al Ahmad Nachar has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Brice Fresneau
Department of Children and Adolescents Oncology, Gustave Roussy, Villejuif, France
18 shared publications - Claire Ducos
Radiation Epidemiology Team, Center for Research in Epidemiology and Population Health, INSERM Unit 1018, Villejuif, France
18 shared publications - Filippo Rosselli
Université Paris-Saclay, Gustave Roussy, CNRS, 94805 Villejuif, France
18 shared publications - Florent de Vathaire
Center for Research in Epidemiology and Population Health - Unit 1018, Université Paris Saclay, Gustave Roussy, Inserm, UVSQ, EpiRad (Radiation Epidemiology Team), Villejuif, France
18 shared publications - Monia Zidane
Radiation Epidemiology Team, CESP, INSERM U1018 , Villejuif 94800
18 shared publications - Nadia Haddy
EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis Cedex, France
18 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S1 from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Table S1 displays all the keywords used to search articles in the Pubmed database.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Table S1 displays all the keywords used to search articles in the Pubmed database.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S3 from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Table S3 displays all the keywords used to search articles in the WOS database.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Table S3 displays all the keywords used to search articles in the WOS database.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S4 from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Table S4 presents the quality control results using the q-genie scale for each article included in this review.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Table S4 presents the quality control results using the q-genie scale for each article included in this review.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S5 from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Table S5 summarizes the reasons behind the exclusion of 15 articles following the review of their full texts.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Table S5 summarizes the reasons behind the exclusion of 15 articles following the review of their full texts.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S2 from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Table S2 displays all the keywords used to search articles in the Scopus database.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Table S2 displays all the keywords used to search articles in the Scopus database.
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Table S4 from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Table S4 presents the quality control results using the q-genie scale for each article included in this review.
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Table S4 presents the quality control results using the q-genie scale for each article included in this review.
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Data from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Second malignant neoplasm (SMN) is one of the most severe long-term risks for childhood cancer survivors (CCS), significantly impacting long-term patient survival. While radiotherapy and chemotherapy are known risk factors, the observed inter-individual variability suggests a genetic component contributing to the risk of SMN. This article aims to conduct a systematic review of genetic factors implicated in the SMN risk among CCS. Searches were performed in PubMed, Scopus, and Web of Sciences. Eighteen studies were included (eleven candidate gene studies, three genome-wide association studies, and four whole exome/genome sequencing studies). The included studies were based on different types of first cancers, investigated any or specific types of SMN, and focused mainly on genes involved in drug metabolism and DNA repair pathways. These differences in study design and methods used to characterize genetic variants limit the scope of the results and highlight the need for further extensive and standardized investigations. However, this review provides a valuable compilation of SMN risk-associated variants and genes, facilitating efficient replication and advancing our understanding of the genetic basis for this major risk for CCS.
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Second malignant neoplasm (SMN) is one of the most severe long-term risks for childhood cancer survivors (CCS), significantly impacting long-term patient survival. While radiotherapy and chemotherapy are known risk factors, the observed inter-individual variability suggests a genetic component contributing to the risk of SMN. This article aims to conduct a systematic review of genetic factors implicated in the SMN risk among CCS. Searches were performed in PubMed, Scopus, and Web of Sciences. Eighteen studies were included (eleven candidate gene studies, three genome-wide association studies, and four whole exome/genome sequencing studies). The included studies were based on different types of first cancers, investigated any or specific types of SMN, and focused mainly on genes involved in drug metabolism and DNA repair pathways. These differences in study design and methods used to characterize genetic variants limit the scope of the results and highlight the need for further extensive and standardized investigations. However, this review provides a valuable compilation of SMN risk-associated variants and genes, facilitating efficient replication and advancing our understanding of the genetic basis for this major risk for CCS.
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Data from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Second malignant neoplasm (SMN) is one of the most severe long-term risks for childhood cancer survivors (CCS), significantly impacting long-term patient survival. While radiotherapy and chemotherapy are known risk factors, the observed inter-individual variability suggests a genetic component contributing to the risk of SMN. This article aims to conduct a systematic review of genetic factors implicated in the SMN risk among CCS. Searches were performed in PubMed, Scopus, and Web of Sciences. Eighteen studies were included (eleven candidate gene studies, three genome-wide association studies, and four whole exome/genome sequencing studies). The included studies were based on different types of first cancers, investigated any or specific types of SMN, and focused mainly on genes involved in drug metabolism and DNA repair pathways. These differences in study design and methods used to characterize genetic variants limit the scope of the results and highlight the need for further extensive and standardized investigations. However, this review provides a valuable compilation of SMN risk-associated variants and genes, facilitating efficient replication and advancing our understanding of the genetic basis for this major risk for CCS.
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Second malignant neoplasm (SMN) is one of the most severe long-term risks for childhood cancer survivors (CCS), significantly impacting long-term patient survival. While radiotherapy and chemotherapy are known risk factors, the observed inter-individual variability suggests a genetic component contributing to the risk of SMN. This article aims to conduct a systematic review of genetic factors implicated in the SMN risk among CCS. Searches were performed in PubMed, Scopus, and Web of Sciences. Eighteen studies were included (eleven candidate gene studies, three genome-wide association studies, and four whole exome/genome sequencing studies). The included studies were based on different types of first cancers, investigated any or specific types of SMN, and focused mainly on genes involved in drug metabolism and DNA repair pathways. These differences in study design and methods used to characterize genetic variants limit the scope of the results and highlight the need for further extensive and standardized investigations. However, this review provides a valuable compilation of SMN risk-associated variants and genes, facilitating efficient replication and advancing our understanding of the genetic basis for this major risk for CCS.
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Table S1 from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Table S1 displays all the keywords used to search articles in the Pubmed database.
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Table S1 displays all the keywords used to search articles in the Pubmed database.
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Table S5 from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Table S5 summarizes the reasons behind the exclusion of 15 articles following the review of their full texts.
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review
Table S5 summarizes the reasons behind the exclusion of 15 articles following the review of their full texts.